Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System.

Parolini C.

Mar Drugs. 2019 Jun 22;17(6). pii: E374. doi: 10.3390/md17060374. Review.

2.

Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids.

Manzini S, Busnelli M, Parolini C, Minoli L, Ossoli A, Brambilla E, Simonelli S, Lekka E, Persidis A, Scanziani E, Chiesa G.

Pharmacol Res. 2019 Mar;141:189-200. doi: 10.1016/j.phrs.2018.12.022. Epub 2018 Dec 26.

PMID:
30593851
3.

Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation.

Busnelli M, Manzini S, Sirtori CR, Chiesa G, Parolini C.

Nutrients. 2018 Sep 6;10(9). pii: E1249. doi: 10.3390/nu10091249. Review.

4.

Lipid phosphate phosphatase 3 in vascular pathophysiology.

Busnelli M, Manzini S, Parolini C, Escalante-Alcalde D, Chiesa G.

Atherosclerosis. 2018 Apr;271:156-165. doi: 10.1016/j.atherosclerosis.2018.02.025. Epub 2018 Mar 2. Review.

PMID:
29518748
5.

Effect of Dietary Components from Antarctic Krill on Atherosclerosis in apoE-Deficient Mice.

Parolini C, Bjorndal B, Busnelli M, Manzini S, Ganzetti GS, Dellera F, Ramsvik M, Bruheim I, Berge RK, Chiesa G.

Mol Nutr Food Res. 2017 Dec;61(12). doi: 10.1002/mnfr.201700098. Epub 2017 Nov 7.

PMID:
28812326
6.

Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE-/- mice.

Busnelli M, Manzini S, Hilvo M, Parolini C, Ganzetti GS, Dellera F, Ekroos K, Jänis M, Escalante-Alcalde D, Sirtori CR, Laaksonen R, Chiesa G.

Sci Rep. 2017 Mar 14;7:44503. doi: 10.1038/srep44503.

7.

Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk Reduction.

Chiesa G, Busnelli M, Manzini S, Parolini C.

Mar Drugs. 2016 Jun 8;14(6). pii: E113. doi: 10.3390/md14060113. Review.

8.

L-homoarginine administration reduces neointimal hyperplasia in balloon-injured rat carotids.

Dellera F, Ganzetti GS, Froio A, Manzini S, Busnelli M, Meinitzer A, Sirtori CR, Chiesa G, Parolini C.

Thromb Haemost. 2016 Aug 1;116(2):400-2. doi: 10.1160/TH15-10-0831. Epub 2016 Jun 9. No abstract available.

9.

High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology: A structural and ultrastructural study.

Arnaboldi F, Busnelli M, Cornaghi L, Manzini S, Parolini C, Dellera F, Ganzetti GS, Sirtori CR, Donetti E, Chiesa G.

Exp Cell Res. 2015 Oct 15;338(1):105-12. doi: 10.1016/j.yexcr.2015.07.032. Epub 2015 Aug 1.

PMID:
26241937
10.

A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.

Parolini C, Vik R, Busnelli M, Bjørndal B, Holm S, Brattelid T, Manzini S, Ganzetti GS, Dellera F, Halvorsen B, Aukrust P, Sirtori CR, Nordrehaug JE, Skorve J, Berge RK, Chiesa G.

PLoS One. 2014 May 19;9(5):e97598. doi: 10.1371/journal.pone.0097598. eCollection 2014.

11.

Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956/1.

Parolini C, Busnelli M, Ganzetti GS, Dellera F, Manzini S, Scanziani E, Johnson JL, Sirtori CR, Chiesa G.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00012.

PMID:
24825406
12.

An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice.

Vik R, Busnelli M, Parolini C, Bjørndal B, Holm S, Bohov P, Halvorsen B, Brattelid T, Manzini S, Ganzetti GS, Dellera F, Nygård OK, Aukrust P, Sirtori CR, Chiesa G, Berge RK.

PLoS One. 2013 Dec 4;8(12):e81963. doi: 10.1371/journal.pone.0081963. eCollection 2013.

13.

Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats.

Parolini C, Manzini S, Busnelli M, Rigamonti E, Marchesi M, Diani E, Sirtori CR, Chiesa G.

Br J Nutr. 2013 Oct;110(8):1394-401. doi: 10.1017/S0007114513000639. Epub 2013 Mar 5.

PMID:
23458494
14.

Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant.

Parolini C, Caligari S, Gilio D, Manzini S, Busnelli M, Montagnani M, Locatelli M, Diani E, Giavarini F, Caruso D, Roda E, Roda A, Sirtori CR, Chiesa G.

Liver Int. 2012 Oct;32(9):1363-71. doi: 10.1111/j.1478-3231.2012.02855.x. Epub 2012 Jul 29.

PMID:
22845860
15.

Cholesterol-lowering effect of dietary Lupinus angustifolius proteins in adult rats through regulation of genes involved in cholesterol homeostasis.

Parolini C, Rigamonti E, Marchesi M, Busnelli M, Cinquanta P, Manzini S, Sirtori CR, Chiesa G.

Food Chem. 2012 Jun 1;132(3):1475-1479. doi: 10.1016/j.foodchem.2011.12.004. Epub 2011 Dec 11.

PMID:
29243638
16.

Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.

Marchesi M, Parolini C, Caligari S, Gilio D, Manzini S, Busnelli M, Cinquanta P, Camera M, Brambilla M, Sirtori CR, Chiesa G.

Br J Pharmacol. 2011 Nov;164(5):1460-8. doi: 10.1111/j.1476-5381.2011.01429.x.

17.

The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease.

Marchesi M, Parolini C, Valetti C, Mangione P, Obici L, Giorgetti S, Raimondi S, Donadei S, Gregorini G, Merlini G, Stoppini M, Chiesa G, Bellotti V.

Biochim Biophys Acta. 2011 Jan;1812(1):87-93. doi: 10.1016/j.bbadis.2010.07.002. Epub 2010 Jul 15.

18.

Hypolipidemic effect of dietary pea proteins: Impact on genes regulating hepatic lipid metabolism.

Rigamonti E, Parolini C, Marchesi M, Diani E, Brambilla S, Sirtori CR, Chiesa G.

Mol Nutr Food Res. 2010 May;54 Suppl 1:S24-30. doi: 10.1002/mnfr.200900251.

PMID:
20077421
19.

Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation.

Badi I, Cinquetti R, Frascoli M, Parolini C, Chiesa G, Taramelli R, Acquati F.

FEBS Lett. 2009 Aug 6;583(15):2486-92. doi: 10.1016/j.febslet.2009.07.001. Epub 2009 Jul 8.

20.

HDL therapy for the treatment of cardiovascular diseases.

Parolini C, Marchesi M, Chiesa G.

Curr Vasc Pharmacol. 2009 Oct;7(4):550-6. Review.

PMID:
19485919

Supplemental Content

Loading ...
Support Center